Raising Funds for New Business Development and M&A Through Warrants
First written in FY2018-Q2. 1 of 3 entries say "Advanced", first in FY2018. Latest entry: FY2020-Q1.
4 other companies' latest entry also says "Dropped".
- FY2020-Q1DroppedAnnual report
「② Status of other stock acquisition rights and similar instruments: Not applicable.」
The stock acquisition rights with provisions for revising the exercise price disclosed in the previous filing are stated as “Not applicable” under the status and exercise status of other stock acquisition rights and similar instruments in this filing. The filing does not describe how the remaining rights will be handled. - FY2018AdvancedAnnual report
「Number of convertible bonds with stock acquisition rights and other instruments with provisions for revising the exercise price exercised during the period: 11,900; number of shares delivered upon exercise during the period: 1,190,000; average exercise price and other terms relating to exercises during the period (yen): 1,166; funds raised through exercises during the period (thousand yen): 1,387,830.」
Of the stock acquisition rights issued through a third-party allotment, 11,900 were exercised, 1,190,000 shares were delivered and ¥1,387,830 thousand was raised. The unexercised portion represents 2,810,000 shares. - FY2018-Q2First statedAnnual report
「The company has issued the First Series of Stock Acquisition Rights through a third-party allotment, with provisions for revising the exercise price and for exercise and suspension designations. Number of stock acquisition rights: 40,000; potential shares from the issuance: 4,000,000; exercise period: 9 January 2018 to 8 January 2021; use of funds: ① investment in research and development for new business development, ② funds reserved for M&A (M&A and capital and business alliance investments).」
The company first specifically disclosed a financing method involving the issuance of stock acquisition rights through a third-party allotment, with the proceeds allocated to research and development investment for new business development and funds reserved for M&A and capital and business alliance investments.